Evaluation of Afatinib in Maintenance Therapy in Squamous Cell Carcinoma of the Head and Neck
Status:
Completed
Trial end date:
2021-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of Afatinib in maintenance
therapy after post-operative radiochemotherapy (66 Gy and Cisplatin at the dose of 100mg/m2
every 3 weeks)in squamous cell carcinoma of the head and neck.